New insights into the pathophysiology and clinical manifestations of schizophrenia

New insights into the genetic risk for schizophrenia, the role of inflammation in schizophrenia pathophysiology, the relationship between negative symptom domains and basic emotions, and cognitive endophenotypes for schizophrenia were presented in an oral presentation session at EPA 2022.

Risk associated with protein-truncating variants in genes implicated in schizophrenia

"The Schizophrenia Exome Sequencing Meta-analysis (SCHEMA) consortium has identified protein-truncating variants (PTVs) in 10 genes associated with schizophrenia", said Professor David Curtis, London, UK.

Most carriers of protein-truncating variants in genes implicated in schizophrenia do not develop schizophrenia

He presented his study of exome-sequenced relatively healthy volunteers from the UK Biobank to determine whether these PTVs increase the risk of schizophrenia in the general population. He identified 251 UK Biobank participants who had PTVs in one of the 10 SCHEMA genes and analyzed the prevalence of psychiatric illness and educational and occupational function among these participants.

"The results showed that most carriers of protein-truncating variants in genes implicated in schizophrenia pathogenesis do not have subclinical manifestations of schizophrenia and do not develop schizophrenia",1 concluded Professor Curtis.

 

Support for an inflammatory role

Long-term antipsychotic treatment significantly reduced the osteopontin level and the neutrophil-to-lymphocyte ratio

Dr Marton Kovacs, Pecs, Hungary, presented a study of 22 patients with schizophrenia he had carried out with colleagues to evaluate the role of inflammation in the pathogenesis of schizophrenia.

"Elevated osteopontin (OPN) and interferon gamma (IFNɣ) serum levels and an increased neutrophil-to-lymphocyte ratio (NLR) were associated with more severe symptoms of schizophrenia", said Dr Kovacs.

In addition, serum OPN level (but not the IFNɣ level) and NLR were significantly decreased in patients on long-term antipsychotic therapy (8.8±5.9 years) compared to patients on short-term therapy (3.5±1.9 weeks).2

 

Relationship between negative symptom domains and basic emotions

A significant negative correlation between blunted affect and recognition of happiness was detected

Dr Marco Zierhut, Berlin, Germany presented a study he carried out with colleagues to explore the relationship between negative symptom domains and six basic emotions (anger, disgust, fear, happiness, sadness, surprise) in 66 patients with schizophrenia spectrum disorders (SSD).

"The results showed a significant negative correlation between blunted affect and recognition of happiness", said Dr Zierhut.3

 

Cognitive endophenotypes for schizophrenia

Executive function and attention appear to be cognitive endophenotypes for schizophrenia

Dr Rosa Ayesa-Arriola, Madrid, Spain, presented a family study of 133 first-episode psychosis (FEP) patients and 244 of their first-degree relatives she carried out with colleagues to explore cognitive function as an endophenotype.4

The results revealed that:

  • FEP patients had the lowest function in all cognitive domains
  • First degree relatives had an intermediate cognitive function between that of FEP patients and healthy controls
  • Parents of patients with FEP who had a diagnosis of schizophrenia had impaired executive function and attention similar to that of their affected offspring4

"Executive function and attention could therefore be suitable cognitive endophenotypes for schizophrenia", concluded Dr Ayesa-Arriola.

 

EPA : European Psychiatric Association
SCHEMA : Schizophrenia Exome Sequencing Meta-analysis  
PTV : protein-truncating variant
UK : United Kingdom 
OPN : osteopontin 
IFNɣ : interferon gamma
NLR : neutrophil-to-lymphocyte ratio 
FEP : first-episode psychosis

BE-NOTPR-0258, approval date : 02.23  

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

References
  1. Curtis D. Clinical features of UK Biobank subjects carrying protein-truncating variants in genes implicated in schizophrenia pathogenesis. Psychiatric Genetics. 2022;32(4):156–61.
  2. Kovács MÁ, Tényi T, Kugyelka R, et al. Elevated osteopontin and interferon gamma serum levels and increased neutrophil-to-lymphocyte ratio are associated with the severity of symptoms in schizophrenia. Front Psychiatry. 2020;10:996.
  3. Zierhut M, Böge K, Bergmann N, et al. The relationship between the recognition of basic emotions and negative symptoms in individuals with schizophrenia spectrum disorders — an exploratory study. Front Psychiatry. 2022;13:865226.
  4. Murillo-García N, Díaz-Pons A, Fernández-Cacho LM, et al. A family study on first episode of psychosis patients: Exploring neuropsychological performance as an endophenotype. Acta Psychiatr Scand. 2022;145(4):384–96.
You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intended for health care professionals.
All the information included in the Website is related to diseases, investigations and existing or potential treatment options and, therefore, directed to health professionals . The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country